Patient-Reported Outcomes (PROs) With Consolidation Durvalumab Versus Placebo Following cCRT in Limited-Stage SCLC: ADRIATIC


Novello S., Cheng Y., Spigel D., Fang J., Chen Y., Zenke Y., ...More

JOURNAL OF THORACIC ONCOLOGY, no.10, 2024 (SCI-Expanded, Scopus) identifier

  • Publication Type: Article / Abstract
  • Publication Date: 2024
  • Journal Name: JOURNAL OF THORACIC ONCOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, MEDLINE
  • Istanbul University-Cerrahpasa Affiliated: Yes